Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miguel García Deltoro

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
AIDS Reviews|July 24, 2019
Rapid Initiation of Antiretroviral Therapy after HIV DiagnosisMiguel García-Deltoro
Enfermedades Infecciosas Y Microbiologia Clinica|February 7, 2009
[Resistance to darunavir]Miguel García Deltoro
Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.)|May 30, 2019
Hepatitis C virus infection and new treatment strategiesMiguel García Deltoro, Carmen Ricart Olmos
AIDS Reviews|December 5, 2014
Genetic barrier to resistance for dolutegravirJosep M Llibre, Federico Pulido, Federico García, et al.
Tropical Medicine & International Health : TM & IH|January 23, 2026
Physician Knowledge of Chagas Disease in a Non-Endemic Country: A Nationwide Cross-Sectional SurveyVictoria Lobo-Antuña, Marta Lobo-Antuña, Alejandro Fernández-Soro, et al.
Plos One|February 8, 2021
Implementation of pre-exposure prophylaxis programme in Spain. Feasibility of four different delivery modelsCarlos Iniesta, Pep Coll, María Jesús Barberá, et al.
AIDS Reviews|February 10, 2017
News on Viral Hepatitis in HIV: Update from the 2016 GEHEP ConferenceEva Poveda, Massimo Puoti, Miguel García-Deltoro, et al.
Journal of Community Health|February 27, 2024
Reassessing HIV Detection Strategies: An Analysis of Opportunistic Screening vs. Indicator-Condition-Driven Diagnosis in Valencia, SpainEnrique Ortega, María Dolores Ocete, María Martínez-Roma, et al.
AIDS (London, England)|January 9, 2018
Interferon-free therapy for treating hepatitis C virus in difficult-to-treat HIV-coinfected patientsCarlos Mínguez, Miguel García-Deltoro, Juan Flores, et al.
AIDS Reviews|August 12, 2024
HIV-1 resistance and virological failure to treatment with the integrase inhibitors bictegravir, cabotegravir, and dolutegravir: a systematic literature reviewJos柩 L Blanco-Arévalo, Miguel García-Deltoro, Miguel Torralba, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
AIDS Reviews|July 24, 2019
Rapid Initiation of Antiretroviral Therapy after HIV DiagnosisMiguel García-Deltoro
Enfermedades Infecciosas Y Microbiologia Clinica|February 7, 2009
[Resistance to darunavir]Miguel García Deltoro
Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.)|May 30, 2019
Hepatitis C virus infection and new treatment strategiesMiguel García Deltoro, Carmen Ricart Olmos
AIDS Reviews|December 5, 2014
Genetic barrier to resistance for dolutegravirJosep M Llibre, Federico Pulido, Federico García, et al.
Tropical Medicine & International Health : TM & IH|January 23, 2026
Physician Knowledge of Chagas Disease in a Non-Endemic Country: A Nationwide Cross-Sectional SurveyVictoria Lobo-Antuña, Marta Lobo-Antuña, Alejandro Fernández-Soro, et al.
Plos One|February 8, 2021
Implementation of pre-exposure prophylaxis programme in Spain. Feasibility of four different delivery modelsCarlos Iniesta, Pep Coll, María Jesús Barberá, et al.
AIDS Reviews|February 10, 2017
News on Viral Hepatitis in HIV: Update from the 2016 GEHEP ConferenceEva Poveda, Massimo Puoti, Miguel García-Deltoro, et al.
Journal of Community Health|February 27, 2024
Reassessing HIV Detection Strategies: An Analysis of Opportunistic Screening vs. Indicator-Condition-Driven Diagnosis in Valencia, SpainEnrique Ortega, María Dolores Ocete, María Martínez-Roma, et al.
AIDS (London, England)|January 9, 2018
Interferon-free therapy for treating hepatitis C virus in difficult-to-treat HIV-coinfected patientsCarlos Mínguez, Miguel García-Deltoro, Juan Flores, et al.
AIDS Reviews|August 12, 2024
HIV-1 resistance and virological failure to treatment with the integrase inhibitors bictegravir, cabotegravir, and dolutegravir: a systematic literature reviewJos柩 L Blanco-Arévalo, Miguel García-Deltoro, Miguel Torralba, et al.
Pageof 4